United Therapeutics buy Royal Bank of Canada
Start price
07.05.26
/
50%
€485.40
Target price
07.05.27
€596.27
Performance (%)
-2.64%
Price
08.06.26
€472.60
Summary
This prediction is currently active. With a performance of -2.64%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 07.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 0.897% | 0.897% |
| iShares Core DAX® | -1,86 % | -1,62 % |
| iShares Nasdaq 100 | -3,32 % | 3,32 % |
| iShares Nikkei 225® | -2,30 % | 3,44 % |
| iShares S&P 500 | -1,31 % | 2,44 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target lowered by Royal Bank Of Canada from $707.00 to $701.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
10.71%
08.06.26
08.06.26
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
29.69%
08.06.26
08.06.26